{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:11:15Z","timestamp":1791288675890,"version":"4.3.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00198-024-07191-5","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T05:01:58Z","timestamp":1723093318000},"page":"1897-1907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials"],"prefix":"10.1007","volume":"35","author":[{"given":"Yuhong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-837X","authenticated-orcid":false,"given":"Guolin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"issue":"1","key":"7191_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11657-018-0549-y","volume":"14","author":"F Yu","year":"2019","unstructured":"Yu F, Xia W (2019) The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos 14(1):32. https:\/\/doi.org\/10.1007\/s11657-018-0549-y","journal-title":"Arch Osteoporos"},{"issue":"7","key":"7191_CR2","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00198-015-3093-2","volume":"26","author":"L Si","year":"2015","unstructured":"Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ (2015) Projection of osteoporosis-related fractures and costs in China: 2010-2050. Osteoporos Int 26(7):1929\u20131937. https:\/\/doi.org\/10.1007\/s00198-015-3093-2","journal-title":"Osteoporos Int"},{"issue":"12","key":"7191_CR3","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00198-017-4175-0","volume":"28","author":"T Saito","year":"2017","unstructured":"Saito T, Sterbenz JM, Malay S, Zhong L, MacEachern MP, Chung KC (2017) Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis. Osteoporos Int 28(12):3289\u20133300. https:\/\/doi.org\/10.1007\/s00198-017-4175-0","journal-title":"Osteoporos Int"},{"key":"7191_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3389\/fphar.2017.00803","volume":"8","author":"V Pavone","year":"2017","unstructured":"Pavone V, Testa G, Giardina SMC, Vescio A, Restivo DA, Sessa G (2017) Pharmacological Therapy of Osteoporosis: A Systematic Current Review of Literature. Front Pharmacol 8:803. https:\/\/doi.org\/10.3389\/fphar.2017.00803","journal-title":"Front Pharmacol"},{"issue":"13","key":"7191_CR5","doi-asserted-by":"publisher","first-page":"e25215","DOI":"10.1097\/md.0000000000025215","volume":"100","author":"K Li","year":"2021","unstructured":"Li K, Gong H, Xie R, Gu J, Wang S, Lin C et al (2021) Clinical efficacy of zoledronic acid combined with percutaneous kyphoplasty in the prevention and treatment of osteoporotic vertebral compression fracture: A systematic review and meta-analysis. Medicine. 100(13):e25215. https:\/\/doi.org\/10.1097\/md.0000000000025215","journal-title":"Medicine."},{"key":"7191_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.wneu.2021.09.131","volume":"157","author":"B Tang","year":"2022","unstructured":"Tang B, Zeng H, Hu S, Liu K, Wu L, Shi X (2022) Percutaneous Vertebroplasty Combined with Zoledronic Acid in Treatment and Prevention of Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis of Comparative Studies. World Neurosurg 157:75\u201387. https:\/\/doi.org\/10.1016\/j.wneu.2021.09.131","journal-title":"World Neurosurg"},{"key":"7191_CR7","doi-asserted-by":"publisher","first-page":"6650358","DOI":"10.1155\/2021\/6650358","volume":"2021","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ma H, Yang F, Tang X, Yi P, Tan M (2021) Clinical Efficacy and Safety of Zoledronic Acid Combined with PVP\/PKP in the Treatment of Osteoporotic Vertebral Compression Fracture: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Biomed Res Int 2021:6650358. https:\/\/doi.org\/10.1155\/2021\/6650358","journal-title":"Biomed Res Int"},{"issue":"23","key":"7191_CR8","doi-asserted-by":"publisher","first-page":"12358","DOI":"10.26355\/eurrev_202012_24030","volume":"24","author":"XG Wu","year":"2020","unstructured":"Wu XG, Zhang DY, Zhu BQ, Li AM (2020) Efficacy of zoledronic acid with percutaneous kyphoplasty\/vertebroplasty in the treatment of osteoporotic vertebral compression fractures: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 24(23):12358\u201312367. https:\/\/doi.org\/10.26355\/eurrev_202012_24030","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"7191_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jamda.2018.02.005","volume":"19","author":"SY Lee","year":"2018","unstructured":"Lee SY, Jung SH, Lee SU, Ha YC, Lim JY (2018) Can Bisphosphonates Prevent Recurrent Fragility Fractures? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Med Dir Assoc 19(5):384\u201390.e1. https:\/\/doi.org\/10.1016\/j.jamda.2018.02.005","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"7191_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00198-014-2903-2","volume":"26","author":"YT Li","year":"2015","unstructured":"Li YT, Cai HF, Zhang ZL (2015) Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 26(2):431\u2013441. https:\/\/doi.org\/10.1007\/s00198-014-2903-2","journal-title":"Osteoporos Int"},{"issue":"5","key":"7191_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4158\/gl-2020-0524","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A et al (2020) Clinical Endocrinologists\/american College Of Endocrinology Clinical Practice Guidelines For The Diagnosis And Treatment Of Postmenopausal Osteoporosis- 2020 Update executive Summary. Endocr Pract 26(5):564\u2013570. https:\/\/doi.org\/10.4158\/gl-2020-0524","journal-title":"Endocr Pract"},{"issue":"3","key":"7191_CR12","first-page":"281","volume":"25","author":"Chinese Society of Osteoporosis and Bone Mineral Research","year":"2019","unstructured":"Chinese Society of Osteoporosis and Bone Mineral Research (2019) Guideline s for the diagnosis and management of primary oste oporosis (2017). Chin J Osteoporos 25(3):281\u2013309","journal-title":"Chin J Osteoporos"},{"issue":"2","key":"7191_CR13","first-page":"93","volume":"23","author":"Group of Trauma Orthopaedics","year":"2021","unstructured":"Group of Trauma Orthopaedics, Chinese Orthopaedic Association, Group of External Fixation and Limb Reconstruction et al (2021) Guidelines for standardized anti-osteoporosis treatment after fragility fractures in China (2021). Chin J Orthop Trauma 23(2):93\u2013101","journal-title":"Chin J Orthop Trauma"},{"issue":"1","key":"7191_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL et al (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17(1):58. https:\/\/doi.org\/10.1007\/s11657-022-01061-5","journal-title":"Arch Osteoporos"},{"issue":"10","key":"7191_CR15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/jbmr.2531","volume":"30","author":"JA Kanis","year":"2015","unstructured":"Kanis JA, McCloskey EV, Harvey NC, Johansson H, Leslie WD (2015) Intervention Thresholds and the Diagnosis of Osteoporosis. J Bone Miner Res 30(10):1747\u20131753. https:\/\/doi.org\/10.1002\/jbmr.2531","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7191_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11657-017-0321-8","volume":"12","author":"A Unnanuntana","year":"2017","unstructured":"Unnanuntana A, Laohaprasitiporn P, Jarusriwanna A (2017) Effect of bisphosphonate initiation at week 2 versus week 12 on short-term functional recovery after femoral neck fracture: a randomized controlled trial. Arch Osteoporos 12(1):27. https:\/\/doi.org\/10.1007\/s11657-017-0321-8","journal-title":"Arch Osteoporos"},{"key":"7191_CR17","doi-asserted-by":"publisher","unstructured":"Laohaprasitiporn P, Jarusriwanna A, Narktang W (2015) Short-term functional recovery between immediate- and delayed bisphosphonate treatment in patients with femoral neck fractures: A randomized controlled trial. J Bone Miner Res 30. https:\/\/doi.org\/10.1002\/jbmr.2763","DOI":"10.1002\/jbmr.2763"},{"issue":"4","key":"7191_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5371\/hp.2015.27.4.258","volume":"27","author":"YJ Cho","year":"2015","unstructured":"Cho YJ, Chun YS, Rhyu KH, Kang JS, Jung GY, Lee JH (2015) Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur? Hip Pelvis 27(4):258\u2013264. https:\/\/doi.org\/10.5371\/hp.2015.27.4.258","journal-title":"Hip Pelvis"},{"issue":"4","key":"7191_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4055\/cios.2016.8.4.437","volume":"8","author":"JB Seo","year":"2016","unstructured":"Seo JB, Yoo JS, Ryu JW, Yu KW (2016) Influence of Early Bisphosphonate Administration for Fracture Healing in Patients with Osteoporotic Proximal Humerus Fractures. Clin Orthop Surg 8(4):437\u2013443. https:\/\/doi.org\/10.4055\/cios.2016.8.4.437","journal-title":"Clin Orthop Surg"},{"key":"7191_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/21514593211058764","volume":"12","author":"D Begkas","year":"2021","unstructured":"Begkas D, Geogrgiadis G, Chatzopoulos ST, Balanika A, Pastroudis A (2021) Effect of Bisphosphonate Administration Starting Time on Healing of Osteoporotic Intertrochanteric Fractures. Geriatr Orthop Surg Rehabil 12:26. https:\/\/doi.org\/10.1177\/21514593211058764","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"1","key":"7191_CR21","first-page":"185","volume":"21","author":"D Begkas","year":"2021","unstructured":"Begkas D, Chatzopoulos ST, Pastroudis A (2021) Effect of early postoperative administration of bisphosphonates on healing of osteoporotic fractures of the distal radius. J Musculoskelet Neuronal Interact 21(1):185","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"7191_CR22","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"11","key":"7191_CR23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"issue":"1","key":"7191_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2106\/jbjs.F.00484","volume":"89","author":"A Moroni","year":"2007","unstructured":"Moroni A, Faldini C, Hoang-Kim A, Pegreffi F, Giannini S (2007) Alendronate improves screw fixation in osteoporotic bone. J Bone Joint Surg Am 89(1):96\u2013101. https:\/\/doi.org\/10.2106\/jbjs.F.00484","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"7191_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/08941939.2017.1339151","volume":"31","author":"B Liu","year":"2018","unstructured":"Liu B, Gan F, Ge Y, Yu H (2018) Clinical Efficacy Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in the Treatment and Prevention of Osteoporotic Vertebral Compression Fractures. J Investig Surg 31(5):425\u2013430. https:\/\/doi.org\/10.1080\/08941939.2017.1339151","journal-title":"J Investig Surg"},{"issue":"7","key":"7191_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1302\/0301-620x.94b7.29079","volume":"94","author":"TY Kim","year":"2012","unstructured":"Kim TY, Ha YC, Kang BJ, Lee YK, Koo KH (2012) Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Joint Surg Br vol 94(7):956\u2013960. https:\/\/doi.org\/10.1302\/0301-620x.94b7.29079","journal-title":"J Bone Joint Surg Br vol"},{"issue":"19","key":"7191_CR27","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2106\/jbjs.K.01434","volume":"94","author":"HS Gong","year":"2012","unstructured":"Gong HS, Song CH, Lee YH, Rhee SH, Lee HJ, Baek GH (2012) Early initiation of bisphosphonate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures. J Bone Joint Surg Am 94(19):1729\u20131736. https:\/\/doi.org\/10.2106\/jbjs.K.01434","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"7191_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00198-008-0767-z","volume":"20","author":"D Cecilia","year":"2009","unstructured":"Cecilia D, J\u00f3dar E, Fern\u00e1ndez C, Resines C, Hawkins F (2009) Effect of alendronate in elderly patients after low trauma hip fracture repair. Osteoporos Int 20(6):903\u2013910. https:\/\/doi.org\/10.1007\/s00198-008-0767-z","journal-title":"Osteoporos Int"},{"issue":"11","key":"7191_CR29","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.2106\/00004623-200311000-00009","volume":"85","author":"CJ Wang","year":"2003","unstructured":"Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Chen HS (2003) The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty. J Bone Joint Surg Am 85(11):2121\u20132126. https:\/\/doi.org\/10.2106\/00004623-200311000-00009","journal-title":"J Bone Joint Surg Am"},{"issue":"11","key":"7191_CR30","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1302\/0301-620x.95b11.31652","volume":"95-b","author":"S Uchiyama","year":"2013","unstructured":"Uchiyama S, Itsubo T, Nakamura K, Fujinaga Y, Sato N, Imaeda T et al (2013) Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time. Bone Joint J 95-b(11):1544\u20131550. https:\/\/doi.org\/10.1302\/0301-620x.95b11.31652","journal-title":"Bone Joint J"},{"key":"7191_CR31","doi-asserted-by":"publisher","first-page":"8039671","DOI":"10.1155\/2020\/8039671","volume":"2020","author":"W Hu","year":"2020","unstructured":"Hu W, Wang H, Shi X, Song Y, Zhang G, Xing S et al (2020) Effect of Preoperative Zoledronic Acid Administration on Pain Intensity after Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures. Pain Res Manag 2020:8039671. https:\/\/doi.org\/10.1155\/2020\/8039671","journal-title":"Pain Res Manag"},{"issue":"3","key":"7191_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5005\/jp-journals-10080-1439","volume":"14","author":"S Sargin","year":"2019","unstructured":"Sargin S, Konya MN, Gulcu A, Aslan A (2019) Effects of Zoledronic Acid Treatment on Fracture Healing, Morbidity and Mortality in Elderly Patients with Osteoporotic Hip Fractures. Strateg Trauma Limb Reconstr 14(3):126\u2013131. https:\/\/doi.org\/10.5005\/jp-journals-10080-1439","journal-title":"Strateg Trauma Limb Reconstr"},{"issue":"7","key":"7191_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00198-020-05816-z","volume":"32","author":"K Lu","year":"2021","unstructured":"Lu K, Yin Y, Li C, Jin Y, Shan HQ (2021) Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study. Osteoporos Int 32(7):1429\u20131439. https:\/\/doi.org\/10.1007\/s00198-020-05816-z","journal-title":"Osteoporos Int"},{"issue":"7","key":"7191_CR34","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1007\/s00402-022-04557-4","volume":"143","author":"K Liu","year":"2023","unstructured":"Liu K, Tan G, Sun W, Lu Q, Tang J, Yu D (2023) Percutaneous kyphoplasty combined with zoledronic acid for the treatment of primary osteoporotic vertebral compression fracture: a prospective, multicenter study. Arch Orthop Trauma Surg 143(7):3699\u20133706. https:\/\/doi.org\/10.1007\/s00402-022-04557-4","journal-title":"Arch Orthop Trauma Surg"},{"issue":"30","key":"7191_CR35","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.3969\/j.issn.2095-4344.0980","volume":"22","author":"L Ji","year":"2018","unstructured":"Ji L, Wei-Biao Z, Zi-Wei H, Yi L (2018) Percutaneous vertebroplasty combined with concurrent and non-concurrent use of zoledronic acid in the treatment of osteoporotic vertebral compression fractures: A 1-year follow-up comparison. Chin J Tissue Eng Res 22(30):4788\u20134793. https:\/\/doi.org\/10.3969\/j.issn.2095-4344.0980","journal-title":"Chin J Tissue Eng Res"},{"issue":"4","key":"7191_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00701-012-1283-7","volume":"154","author":"C Li","year":"2012","unstructured":"Li C, Wang HR, Li XL, Zhou XG, Dong J (2012) The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir 154(4):731\u2013738. https:\/\/doi.org\/10.1007\/s00701-012-1283-7","journal-title":"Acta Neurochir"},{"key":"7191_CR37","doi-asserted-by":"publisher","first-page":"3223437","DOI":"10.1155\/2022\/3223437","volume":"2022","author":"L Qian","year":"2022","unstructured":"Qian L, Chen Q, Wang D, Pan Q, Jian Q, Ma Y (2022) Study on the Relationship between the Use of Bisphosphonates for Antiosteoporosis and Vertebral Re-Fracture after Vertebroplasty. Evid Based Complement Alternat Med 2022:3223437. https:\/\/doi.org\/10.1155\/2022\/3223437","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"7191_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/os.12460","volume":"11","author":"Z Liu","year":"2019","unstructured":"Liu Z, Li CW, Mao YF, Liu K, Liang BC, Wu LG et al (2019) Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures. Orthop Surg 11(3):380\u2013385. https:\/\/doi.org\/10.1111\/os.12460","journal-title":"Orthop Surg"},{"issue":"3","key":"7191_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00198-020-05637-0","volume":"32","author":"K Zhu","year":"2021","unstructured":"Zhu K, Zhang J, Zhang C, Zhao Z, Gao J, Li X et al (2021) Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture. Osteoporos Int 32(3):559\u2013564. https:\/\/doi.org\/10.1007\/s00198-020-05637-0","journal-title":"Osteoporos Int"},{"issue":"5","key":"7191_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cjtee.2016.07.001","volume":"19","author":"Y Li","year":"2016","unstructured":"Li Y, Zhao WB, Wang DL, He Q, Li Q, Pei FX et al (2016) Treatment of osteoporotic intertrochanteric fractures by zoledronic acid injection combined with proximal femoral nail anti-rotation. Chin J Traumatol 19(5):259\u2013263. https:\/\/doi.org\/10.1016\/j.cjtee.2016.07.001","journal-title":"Chin J Traumatol"},{"issue":"7","key":"7191_CR41","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00198-019-04896-w","volume":"30","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang T, Xu X, Cai Q, Zhao D (2019) Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women. Osteoporos Int 30(7):1475\u20131480. https:\/\/doi.org\/10.1007\/s00198-019-04896-w","journal-title":"Osteoporos Int"},{"issue":"3","key":"7191_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/os.12338","volume":"9","author":"Y Ding","year":"2017","unstructured":"Ding Y, Zeng JC, Yin F, Zhang CL, Zhang Y, Li SX et al (2017) Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5\u2009mg in Chinese Women with Postmenopausal Osteoporosis. Orthop Surg 9(3):284\u2013289. https:\/\/doi.org\/10.1111\/os.12338","journal-title":"Orthop Surg"},{"issue":"6","key":"7191_CR43","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1210\/jc.2011-3060","volume":"97","author":"MH Murad","year":"2012","unstructured":"Murad MH, Drake MT, Mullan RJ, Mauck KF, Stuart LM, Lane MA et al (2012) Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab 97(6):1871\u20131880. https:\/\/doi.org\/10.1210\/jc.2011-3060","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7191_CR44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00774-014-0646-y","volume":"34","author":"H Tsuchie","year":"2016","unstructured":"Tsuchie H, Miyakoshi N, Kasukawa Y, Nishi T, Abe H, Segawa T et al (2016) The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture. J Bone Miner Metab 34(1):86\u201391. https:\/\/doi.org\/10.1007\/s00774-014-0646-y","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"7191_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12891-017-1509-1","volume":"18","author":"A Iwata","year":"2017","unstructured":"Iwata A, Kanayama M, Oha F, Hashimoto T, Iwasaki N (2017) Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study. BMC Musculoskelet Disord 18(1):148. https:\/\/doi.org\/10.1186\/s12891-017-1509-1","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"7191_CR46","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00198-019-05125-0","volume":"30","author":"HK Min","year":"2019","unstructured":"Min HK, Ahn JH, Ha KY, Kim YH, Kim SI, Park HY et al (2019) Effects of anti-osteoporosis medications on radiological and clinical results after acute osteoporotic spinal fractures: a retrospective analysis of prospectively designed study. Osteoporos Int 30(11):2249\u20132256. https:\/\/doi.org\/10.1007\/s00198-019-05125-0","journal-title":"Osteoporos Int"},{"issue":"22","key":"7191_CR47","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.2106\/jbjs.15.01217","volume":"98","author":"P Aspenberg","year":"2016","unstructured":"Aspenberg P, Malouf J, Tarantino U, Garc\u00eda-Hern\u00e1ndez PA, Corradini C, Overgaard S et al (2016) Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks. J Bone Joint Surg Am 98(22):1868\u20131878. https:\/\/doi.org\/10.2106\/jbjs.15.01217","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"7191_CR48","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00198-003-1507-z","volume":"14","author":"AR McLellan","year":"2003","unstructured":"McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14(12):1028\u20131034. https:\/\/doi.org\/10.1007\/s00198-003-1507-z","journal-title":"Osteoporos Int"},{"issue":"4","key":"7191_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5371\/hp.2022.34.4.191","volume":"34","author":"YK Oh","year":"2022","unstructured":"Oh YK, Moon NH, Shin WC (2022) Management of Osteoporosis Medication after Osteoporotic Fracture. Hip Pelvis 34(4):191\u2013202. https:\/\/doi.org\/10.5371\/hp.2022.34.4.191","journal-title":"Hip Pelvis"},{"issue":"14","key":"7191_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12114\/j.issn.1007-9572.2023.0121","volume":"26","author":"Chinese Society of Osteoporosis and Bone Mineral Research","year":"2023","unstructured":"Chinese Society of Osteoporosis and Bone Mineral Research (2023) Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022). Chin Gen Pract 26(14):22. https:\/\/doi.org\/10.12114\/j.issn.1007-9572.2023.0121","journal-title":"Chin Gen Pract"},{"key":"7191_CR51","doi-asserted-by":"publisher","unstructured":"Danazumi MS, Lightbody N, Dermody G (2024) Effectiveness of fracture liaison service in reducing the risk of secondary fragility fractures in adults aged 50 and older: a systematic review and meta-analysis. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-024-07052-1","DOI":"10.1007\/s00198-024-07052-1"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07191-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T10:03:31Z","timestamp":1729677811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07191-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7191"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07191-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"24 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Yuhong Zeng, Yuan Yang, Jue Wang, and Guolin Meng declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}